This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Ben-Gurion University of the Negev Research and Development Authority. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2021
Title: Yosi Shamay: Innovator in Cell-Penetrating Peptide-Polymer Conjugates
Introduction
Yosi Shamay is a notable inventor based in Kfar Sabbah, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of innovative conjugates for diagnostic and therapeutic applications. With a total of 4 patents to his name, Shamay's work is paving the way for advancements in intracellular delivery systems.
Latest Patents
One of Yosi Shamay's latest patents focuses on caged cell-penetrating peptide-polymer conjugates. These conjugates are designed for the intracellular delivery of a wide range of cargoes, including various nanoparticle pharmaceutical carriers such as liposomes, micelles, microparticles, nanoparticles, and polymer-conjugates. The invention includes a detectable agent or a therapeutic agent, providing a novel strategy for site-specific delivery to appropriate tissues in a subject. The versatile applications of these conjugates in diagnostics and imaging are also highlighted.
Career Highlights
Yosi Shamay is affiliated with the Ben-Gurion University of the Negev Research and Development Authority. His work at this esteemed institution has allowed him to explore and develop groundbreaking technologies that have the potential to transform medical diagnostics and treatment methodologies.
Collaborations
Shamay collaborates with talented individuals in his field, including Ayelet David and Gonen Ashkenasy. These partnerships enhance the innovative capacity of his research and contribute to the successful development of his patented technologies.
Conclusion
Yosi Shamay's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work on caged cell-penetrating peptide-polymer conjugates is a testament to the potential of targeted delivery systems in improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
